Literature DB >> 9557693

Control of adenovirus early gene expression during the late phase of infection.

S P Fessler1, C S Young.   

Abstract

The adenovirus gene regulatory program occurs in two distinct phases, as defined by the onset of DNA replication. During the early phase, the E1A, E1B, E2, E3, and E4 genes are maximally expressed, while the major late promoter (MLP) is minimally expressed and transcription is attenuated. After the onset of DNA replication, the IVa2 and pIX genes are expressed at high levels, transcription from the MLP is unattenuated and fully activated, and early gene expression is repressed. Although the cis elements and trans-acting factors responsible for the late-phase activation of the MLP have been identified and characterized and the role of DNA replication in activation has been established, the mechanism(s) underlying the commensurate decrease in early gene expression has yet to be elucidated. The results of this study demonstrate that this decrease depends on a fully functional MLP. Specifically, virus mutants with severely deficient transcription from the MLP exhibit a marked increase in expression of the E1A, E1B, and E2 early genes. These increases were observed at the level of transcription initiation, mRNA accumulation, and protein production. In addition, expression from the late gene pIX, which is not contained within the major late transcription unit (MLTU), is also markedly increased. To begin the analysis of the mechanisms underlying these late-phase effects, mixed-infection experiments with mutant and wild-type viruses were performed. The results show that the effects on early gene expression, as measured both at the protein and RNA levels, are mediated in trans and not in cis. These observations are consistent either with a model in which one or more late protein products encoded by the MLTU acts as a repressor of early gene expression or with one in which the wild-type MLP competes with early promoters for limiting transcription factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557693      PMCID: PMC109633          DOI: 10.1128/JVI.72.5.4049-4056.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Adenovirus early region 4 stimulates mRNA accumulation via 5' introns.

Authors:  K Nordqvist; G Akusjärvi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Differential regulation of adenovirus late transcriptional units by the products of early region.

Authors:  E Bridge; C Hemström; U Pettersson
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

4.  The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species.

Authors:  B W Hayes; G C Telling; M M Myat; J F Williams; S J Flint
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus.

Authors:  M J Ensinger; H S Ginsberg
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

6.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

7.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

8.  The metabolism of host RNAs in cells infected by an adenovirus E4 mutant.

Authors:  A B Sandler; G Ketner
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

9.  The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein.

Authors:  A Babich; J R Nevins
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

10.  Transcription from the adenovirus major late promoter uses redundant activating elements.

Authors:  M Reach; L X Xu; C S Young
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  15 in total

1.  Roles for non-TATA core promoter sequences in transcription and factor binding.

Authors:  B S Wolner; J D Gralla
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background.

Authors:  Robin N Shepard; David A Ornelles
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Effects of adeno-associated virus on adenovirus replication and gene expression during coinfection.

Authors:  Jennifer M Timpe; Kristin C Verrill; James P Trempe
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection.

Authors:  Kai Wu; Diana Orozco; Patrick Hearing
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Mutual interference of adenovirus infection and myc expression.

Authors:  Kristina Löhr; Oliver Hartmann; Helmut Schäfer; Matthias Dobbelstein
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 6.  Conditionally replicating adenoviruses for cancer treatment.

Authors:  Youssef Jounaidi; Joshua C Doloff; David J Waxman
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

7.  TBP flanking sequences: asymmetry of binding, long-range effects and consensus sequences.

Authors:  Hana Faiger; Marina Ivanchenko; Ilana Cohen; Tali E Haran
Journal:  Nucleic Acids Res       Date:  2006-01-10       Impact factor: 16.971

8.  Significant differences in terms of codon usage bias between bacteriophage early and late genes: a comparative genomics analysis.

Authors:  Oriah Mioduser; Eli Goz; Tamir Tuller
Journal:  BMC Genomics       Date:  2017-11-13       Impact factor: 3.969

9.  Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.

Authors:  Yasuaki Yamakawa; Hiroshi Tazawa; Joe Hasei; Shuhei Osaki; Toshinori Omori; Kazuhisa Sugiu; Tadashi Komatsubara; Kouji Uotani; Tomohiro Fujiwara; Aki Yoshida; Toshiyuki Kunisada; Yasuo Urata; Shunsuke Kagawa; Toshifumi Ozaki; Toshiyoshi Fujiwara
Journal:  Cancer Sci       Date:  2017-08-03       Impact factor: 6.716

10.  A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation.

Authors:  Wilhelm Ching; Emre Koyuncu; Sonia Singh; Christina Arbelo-Roman; Barbara Hartl; Elisabeth Kremmer; Thomas Speiseder; Chris Meier; Thomas Dobner
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.